Evidence map›Paper›PMID 32582943›Full record

ArticleThe Journal of infectious diseases2020

Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.

Teck Chuan Voo, Hannah Clapham, Clarence C Tam

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Vaccine Passports and Political Legitimacy: A Public Reason Framework for Policymakers.Ethical theory and moral practice : an international forum · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Immunity certification for COVID-19: ethical considerations.Bulletin of the World Health Organization · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Teck Chuan VooCentre of Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.
Hannah ClaphamSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Clarence C TamSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
National University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of countries are planning the use of "immunity passports" as a way to ease restrictive measures and allow infected and recovered people to return to work during the COVID-19 pandemic. This paper brings together key scientific uncertainties regarding the use of serological tests to assure immune status and a public health ethics perspective to inform key considerations in the ethical implementation of immunity passport policies. Ill-conceived policies have the potential to cause severe unintended harms that could result in greater inequity, the stigmatization of certain sectors of society, and heightened risks and unequal treatment of individuals due to erroneous test results. Immunity passports could, however, be used to achieve collective benefits and benefits for specific populations besides facilitating economic recovery. We conclude that sector-based policies that prioritize access to testing based on societal need are likely to be fairer and logistically more feasible, while minimizing stigma and reducing incentives for fraud. Clear guidelines need to be set out for which sectors of society should be prioritized for testing, and rigorous mechanisms should be in place to validate test results and identify cases of reinfection.

Indexed as

BetacoronavirusCertificationClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingHealth PolicyHumansImmunityPandemicsPneumonia, ViralPublic HealthSARS-CoV-2Serologic TestscoronavirusCOVID-19disease control policyequityethicsimmunity passportsSARS-CoV-2serological assaysstigma

Identifiers

PMID32582943
PMCPMC7337820
OpenAlexW3033230380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.